Posted by Michael Wonder on 24 Oct 2022
Saskatchewan becomes sixth Canadian province to implement a biosimilar switching policy
21 October 2022 - Saskatchewan joined five provinces and one territory in implementing a biosimilar switching policy, allowing for reference products to be switched out for biosimilars and lowering drug costs for the province’s public health plan.
The Saskatchewan Ministry of Health announced that it will implement a biosimilars switching policy, making it the sixth Canadian province and seventh jurisdiction to do so. Saskatchewan joins British Columbia, Quebec, Alberta, New Brunswick, Nova Scotia, and the Northwest Territories.
